Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed alone, and
Erlotinib alone, as Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
Pemetrexed
H3E-MC-S103
NCT00550173
Nonsquamous Non-Small Cell Lung Cancer
Phase 2
 
The annotated case report form is not available. A blank case report form will be provided.
June 2015

Powered by ideaPoint, Inc.